The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Open accessAbstract
In July 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the search results. Following this review, the ASH Committee on Quality agreed to continue monitoring the supporting evidence rather than revise or retire these guidelines at this time. Limited searches and expert review will be repeated annually going forward until these guidelines are revised or retired. Background: Clinicians confront numerous practical issues in optimizing the use of anticoagulants to treat venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians and other health care professionals in their decisions about the use of anticoagulants in the management of VTE. These guidelines assume the choice of anticoagulant has already been made. Methods: ASH formed a multidisciplinary guideline panel balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic evidence reviews. The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations, which were subject to public comment. Results: The panel agreed on 25 recommendations and 2 good practice statements to optimize management of patients receiving anticoagulants. Conclusions: Strong recommendations included using patient self-management of international normalized ratio (INR) with home point-of-care INR monitoring for vitamin K antagonist therapy and against using periprocedural low-molecular-weight heparin (LMWH) bridging therapy. Conditional recommendations included basing treatment dosing of LMWH on actual body weight, not using anti–factor Xa monitoring to guide LMWH dosing, using specialized anticoagulation management services, and resuming anticoagulation after episodes of life-threatening bleeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Self-citationClinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“In general, adherence to prescribed medication regimens is associated with improved clinical outcomes for patients with chronic conditions, and nonadherence is associated with higher rates of hospital admissions, suboptimal health outcomes, increased morbidity and mortality, and increased health care costs.(160,161) I…”
BackgroundPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Prevention of VTE in Orthopedic Surgery Patients
Falck-Ytter, Y., Francis, C. W., Johanson, N. A., Curley, C., Dahl, O. E., Schulman, S., Ortel, T. L., Pauker, S. G., & Colwell, C. W. (2012) · Chest · doi:10.1378/chest.11-2404 · Cited by 1,930
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911 · cited 2×
“In brief, the panel brainstormed all possible outcomes and then rated their relative importance for decision-making following the GRADE approach.(22) During this rating process, the panel used definitions of the outcomes (“marker states”) developed for these guidelines.”
MethodSelf-citationIdarucizumab for Dabigatran Reversal
Pollack, C. V., Reilly, P. A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kamphuisen, P. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502000 · Cited by 1,552
Alonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., et al. (2016) · BMJ · doi:10.1136/bmj.i2016 · Cited by 1,317
Self-citationAndrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Self-citationEvidence-Based Management of Anticoagulant Therapy
Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Kovacs, M. J., Svensson, P. J., Veenstra, D. L., Crowther, M., & Guyatt, G. H. (2012) · Chest · doi:10.1378/chest.11-2295 · Cited by 1,269
Self-citationAtkins, D., Eccles, M., Flottorp, S., Guyatt, G. H., Henry, D., Hill, S., Liberati, A., O'Connell, D., Oxman, A. D., Phillips, B., et al. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-38 · Cited by 1,235
Self-citationIdarucizumab for dabigatran reversal
Garrett, A. D., PharmD, & Bcps (2015) · Cited by 1,167
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Pollack, C. V., Reilly, P. A., van Ryn, J., Eikelboom, J. W., Glund, S., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kam, C.-W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707278 · Cited by 1,154
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
Self-citationSarode, R., Milling, T. J., Refaai, M. A., Mangione, A., Schneider, A., Durn, B. L., & Goldstein, J. N. (2013) · Circulation · doi:10.1161/circulationaha.113.002283 · Cited by 813
Conflict of Interest in Medical Research, Education, and Practice
(2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 807
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Connolly, S. J., Milling, T. J., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Gold, A., Bronson, M. D., Lu, G., Conley, P. B., Verhamme, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607887 · Cited by 807
Self-citationSchünemann, H. J., Wiercioch, W., Etxeandia, I., Falavigna, M., Santesso, N., Mustafa, R., Ventresca, M., Brignardello-Petersen, R., Laisaar, K.-T., Kowalski, S., et al. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131237 · Cited by 686
Self-citationSchünemann, H. J., Wiercioch, W., Brozek, J., Etxeandia-Ikobaltzeta, I., Mustafa, R. A., Manja, V., Brignardello-Petersen, R., Neumann, I., Falavigna, M., Alhazzani, W., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.09.009 · Cited by 645
Self-citationChiquette, E., Amato, M. G., & Bussey, H. I. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1641 · Cited by 596
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
Birnie, D. H., Healey, J. S., Wells, G. A., Verma, A., Tang, A. S., Krahn, A. D., Simpson, C. S., Ayala-Paredes, F., Coutu, B., Leiria, T. L. L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302946 · Cited by 579
Kuramatsu, J. B., Gerner, S. T., Schellinger, P. D., Glahn, J., Endres, M., Sobesky, J., Flechsenhar, J., Neugebauer, H., Jüttler, E., Grau, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.0846 · Cited by 568
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
Lim, W., Dentali, F., Eikelboom, J. W., & Crowther, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-9-200605020-00011 · Cited by 443
Self-citationSiegal, D., Yudin, J., Kaatz, S., Douketis, J. D., Lim, W., & Spyropoulos, A. C. (2012) · Circulation · doi:10.1161/circulationaha.112.105221 · Cited by 440
Beyer-Westendorf, J., Förster, K., Pannach, S., Ebertz, F., Gelbricht, V., Thieme, C., Michalski, F., Köhler, C., Werth, S., Sahin, K., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563577 · Cited by 407
Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., Roberts, T. E., Sanghera, S., Barton, P., Gray, R., Kai, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19880 · Cited by 399
Beyer-Westendorf, J., Gelbricht, V., Forster, K., Ebertz, F., Kohler, C., Werth, S., Kuhlisch, E., Stange, T., Thieme, C., Daschkow, K., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht557 · Cited by 383
Steiner, T., Poli, S., Griebe, M., Hüsing, J., Hajda, J., Freiberger, A., Bendszus, M., Bösel, J., Christensen, H., Dohmen, C., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00110-1 · Cited by 379
Beyth, R. J., Quinn, L., & Landefeld, C. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00010 · Cited by 360
Sawicki, P. T. (1999) · JAMA · doi:10.1001/jama.281.2.145 · Cited by 351
Schünemann, H. J., Mustafa, R., Brozek, J., Santesso, N., Alonso-Coello, P., Guyatt, G., Scholten, R., Langendam, M., Leeflang, M. M., Akl, E. A., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.032 · Cited by 350
Self-citationWitt, D. M., Sadler, M. A., Shanahan, R. L., Mazzoli, G., & Tillman, D. J. (2005) · Chest · doi:10.1378/chest.127.5.1515 · Cited by 348
Self-citationSchünemann, H. J., Al-Ansary, L. A., Forland, F., Kersten, S., Komulainen, J., Kopp, I. B., Macbeth, F., Phillips, S. M., Robbins, C., van der Wees, P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1885 · Cited by 337 · cited 7×
“During all deliberations, panel members with a current, direct financial interest in a commercial entity with any product that could be affected by the guidelines were recused from making judgments about relevant recommendations.(5,18-20) The Evidence-to-Decision (EtD) framework for each recommendation describes which…”
BackgroundMethodInfluentialMajeed, A., Ågren, A., Holmström, M., Bruzelius, M., Chaireti, R., Odeberg, J., Hempel, E.-L., Magnusson, M., Frisk, T., & Schulman, S. (2017) · Blood · doi:10.1182/blood-2017-05-782060 · Cited by 326
The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution
Guyatt, G., Akl, E. A., Hirsh, J., Kearon, C., Crowther, M., Gutterman, D., Lewis, S. Z., Nathanson, I., Jaeschke, R., & Schünemann, H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00254 · Cited by 325
Self-citationMarchesi, C., Pierfranceschi, M., Crowther, M., Garcia, D., Hylek, E., Witt, D., Clark, N., Squizzato, A., Imberti, D., Ageno, W., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-01-0052 · Cited by 306
Self-citationCromheecke, M. E., Levi, M., Colly, L. P., de Mol, B. J., Prins, M. H., Hutten, B. A., Mak, R., Keyzers, K. C., & Büller, H. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02470-3 · Cited by 293
Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations.
Schünemann, H. J., Best, D., Vist, G. E., & Oxman, A. D. (2003) · PubMed Central · Cited by 289
Effect of home testing of international normalized ratio on clinical events
Matchar, D. B., Jacobson, A., Dolor, R., Edson, R., Uyeda, L., Phibbs, C. S., Vertrees, J. E., Shih, M.-C., Holodniy, M., & Lavori, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002617 · Cited by 266
Self-monitoring and self-management of oral anticoagulation
Heneghan, C. J., Garcia-Alamino, J. M., Spencer, E. A., Ward, A. M., Perera, R., Bankhead, C., Alonso Coello, P., Fitzmaurice, D., Mahtani, K. R., & Onakpoya, I. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003839.pub3 · Cited by 256
Witt, D. M., Delate, T., Garcia, D. A., Clark, N. P., Hylek, E. M., Ageno, W., Dentali, F., & Crowther, M. A. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.4261 · Cited by 236
Self-citationOptimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Majeed, A., Kim, Y.-K., Roberts, R. S., Holmström, M., & Schulman, S. (2010) · Stroke · doi:10.1161/strokeaha.110.593087 · Cited by 219
Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation
Qureshi, W., Mittal, C., Patsias, I., Garikapati, K., Kuchipudi, A., Cheema, G., Elbatta, M., Alirhayim, Z., & Khalid, F. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.044 · Cited by 218
Gross, P., Ritchie, B., Nahirniak, S., Lin, Y., Lieberman, L., Carrier, M., Crowther, M., Ghosh, I., Lazo-Langner, A., Zondag, M., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1636541 · Cited by 218
Self-citationUse of Factor IX Complex in Warfarin-related Intracranial Hemorrhage
Boulis, N. M., Bobek, M. P., Schmaier, A., & Hoff, J. T. (1999) · Neurosurgery · doi:10.1097/00006123-199911000-00020 · Cited by 215
Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074037 · Cited by 209
Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial
Menéndez-Jándula, B., Souto, J. C., Oliver, A., Montserrat, I., Quintana, M., Gich, I., Bonfill, X., & Fontcuberta, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00006 · Cited by 208
Chai-Adisaksopha, C., Hillis, C., Siegal, D. M., Movilla, R., Heddle, N., Crowther, M., & Iorio, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-04-0266 · Cited by 190
Self-citationTreatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial
Crowther, M. A., Julian, J., McCarty, D., Douketis, J., Kovacs, M., Biagoni, L., Schnurr, T., McGinnis, J., Gent, M., Hirsh, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03125-1 · Cited by 177
Self-citationKhan, T. I., Kamali, F., Kesteven, P., Avery, P., & Wynne, H. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05074.x · Cited by 176
Piccini, J. P., Garg, J., Patel, M. R., Lokhnygina, Y., Goodman, S. G., Becker, R. C., Berkowitz, S. D., Breithardt, G., Hacke, W., Halperin, J. L., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu083 · Cited by 170
Pharmacology of anticoagulants used in the treatment of venous thromboembolism
Nutescu, E. A., Burnett, A., Fanikos, J., Spinler, S., & Wittkowsky, A. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1314-3 · Cited by 166
Purrucker, J. C., Haas, K., Rizos, T., Khan, S., Wolf, M., Hennerici, M. G., Poli, S., Kleinschnitz, C., Steiner, T., Heuschmann, P. U., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3682 · Cited by 163
Connock, M., Stevens, C., Fry-Smith, A., Jowett, S., Fitzmaurice, D., Moore, D., & Song, F. (2007) · Health Technology Assessment · doi:10.3310/hta11380 · Cited by 158
Neiman, A. B., Ruppar, T. M., Ho, P. M., Garber, L., Weidle, P. J., Hong, Y., George, M. G., & Thorpe, P. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6645a2 · Cited by 158
National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
Dlott, J. S., George, R., Huang, X., Odeh, M. A., Kaufman, H. W., Ansell, J., & Hylek, E. M. (2014) · Circulation · doi:10.1161/circulationaha.113.002601 · Cited by 155
Self-citationOral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin
Crowther, M. A., Ageno, W., Garcia, D. A., Wang, L., Witt, D. M., Clark, N. P., Blostein, M. D., Kahn, S. R., Vesely, S. K., Schulman, S., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-5-200903030-00005 · Cited by 155
Self-citationDabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
Kim, J. S., She, F., Jongnarangsin, K., Chugh, A., Latchamsetty, R., Ghanbari, H., Crawford, T. C., Suwanagool, A., Sinno, M., Carrigan, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.011 · Cited by 146
Perioperative Management of Dabigatran
Schulman, S., Carrier, M., Lee, A. Y. Y., Shivakumar, S., Blostein, M. D., Spencer, F. A., Solymoss, S., Barty, R., Wang, G., Heddle, N. M., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015688 · Cited by 146
Site-Level Variation in and Practices Associated With Dabigatran Adherence
Shore, S., Ho, P. M., Lambert‐Kerzner, A., Glorioso, T. J., Carey, E., Cunningham, F., Longo, L., Jackevicius, C. A., Rose, A. J., & Turakhia, M. P. (2015) · JAMA · doi:10.1001/jama.2015.2761 · Cited by 145
Treatment of Excessive Anticoagulation With Phytonadione (Vitamin K): A Meta-analysis
DeZee, K. J. (2006) · Archives of Internal Medicine · doi:10.1001/.391 · Cited by 139
Gadisseur, A., Kaptein, A. A., Breukink-Engbers, W. G. M., van der Meer, F. J. M., & Rosendaal, F. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00659.x · Cited by 139
Gerner, S. T., Kuramatsu, J. B., Sembill, J. A., Sprügel, M. I., Endres, M., Hæusler, K. G., Vajkoczy, P., Ringleb, P. A., Purrucker, J. C., Rizos, T., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25134 · Cited by 139
Sengupta, N., Feuerstein, J. D., Patwardhan, V. R., Tapper, E. B., Ketwaroo, G. A., Thaker, A. M., & Leffler, D. A. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.398 · Cited by 136
Self management of oral anticoagulation: randomised trial
Fitzmaurice, D. A., Murray, E. T., McCahon, D., Holder, R. L., Raftery, J. P., Hussain, S., Sandhar, H., & Hobbs, R. F. (2005) · BMJ · doi:10.1136/bmj.38618.580903.ae · Cited by 125
Randomized trial of lottery-based incentives to improve warfarin adherence
Kimmel, S. E., Troxel, A. B., Loewenstein, G. F., Brensinger, C. M., Jaskowiak, J., Doshi, J. A., Laskin, M. S., & Volpp, K. G. M. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.05.005 · Cited by 121
Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Claassen, D. O., Kazemi, N. J., Zubkov, A. Y., Wijdicks, E. F. M., & Rabinstein, A. A. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1313 · Cited by 119
Mazor, K. M., Baril, J. L., Dugan, E., Spencer, F. A., Burgwinkle, P., & Gurwitz, J. H. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.08.010 · Cited by 118
Gadisseur, A., Breukink-Engbers, W. G. M., van der Meer, F. J. M., van den Besselaar, A. M. H. P., Sturk, A., & Rosendaal, F. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.21.2639 · Cited by 118
Schünemann, H. J., Osborne, M. L., Moss, J., Manthous, C. A., Wagner, G. R., Sicilian, L., Ohar, J. A., McDermott, S., Lucas, L., & Jaeschke, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0126st · Cited by 115
Anticoagulation in Hospitalized Patients With Renal Insufficiency
Thorevska, N. Y., Amoateng‐Adjepong, Y., Sabahi, R., Schiopescu, I., Salloum, A., Muralidharan, V., & Manthous, C. A. (2004) · CHEST Journal · doi:10.1378/chest.125.3.856 · Cited by 109
Brittenden, J., Cotton, S. C., Elders, A., Tassie, E., Scotland, G., Ramsay, C. R., Norrie, J. D., Burr, J. M., Francis, J., Wileman, S., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19270 · Cited by 107
Nielsen, P. B., Larsen, T. B., Skjøth, F., & Lip, G. Y. H. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9369 · Cited by 107
Egan, G., & Ensom, M. H. H. (2015) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v68i1.1423 · Cited by 104
Pernod, G., Labarère, J., Yver, J., Satger, B., Allenet, B., Berremili, T., Fontaine, M., Franco, G., & Bosson, J. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0690-1 · Cited by 103
Chai‐Adisaksopha, C., Hillis, C., Monréal, M., Witt, D. M., & Crowther, M. A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-01-0063 · Cited by 98
Self-citationGuha, D., Coyne, S., & Macdonald, R. L. (2015) · Journal of neurosurgery · doi:10.3171/2015.2.jns141889 · Cited by 96
Laboratory testing of anticoagulants: the present and the future
Favaloro, E. J., Lippi, G., & Koutts, J. (2011) · Pathology · doi:10.1097/pat.0b013e32834bf5f4 · Cited by 95
Wilson, J.-A. S., Wilbur, K., Burton, E., & Anderson, D. R. (2001) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000048043 · Cited by 95
Yung, D., Kapral, M. K., Asllani, E., Fang, J., & Lee, D. S. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.10.002 · Cited by 93
Koertke, H., Zittermann, A., Tenderich, G., Wagner, O., El-Arousy, M., Krian, A., Ennker, J., Taborski, U., Klövekorn, W. P., Moosdorf, R., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm391 · Cited by 93
Hamad, M. A. S., van Eekelen, E., van Agt, T., & van Straten, A. H. M. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2008.10.020 · Cited by 90
Verret, L., Avez‐Couturier, J., Rozon, A., Saudrais‐Janecek, S., St‐Onge, A., Nguyen, A., Basmadjian, A., Tremblay, S., Brouillette, D., & de Denus, S. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2012.01116 · Cited by 89
Grandhi, R., Newman, W. C., Zhang, X., Harrison, G. L., Moran, C. C., Okonkwo, D. O., & Ducruet, A. F. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.08.042 · Cited by 87
Schulman, S., Parpia, S., Stewart, C., Rudd-Scott, L., Julian, J. A., & Levine, M. N. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-10-201111150-00003 · Cited by 86
Akl, E. A., El-Hachem, P., Abou‐Haidar, H., Neumann, I., Schünemann, H. J., & Guyatt, G. H. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.05.006 · Cited by 82
Self-citationThe cost-effectiveness of different management strategies for patients on chronic warfarin therapy
Lafata, J. E., Martin, S. A., Kaatz, S., & Ward, R. E. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.01239.x · Cited by 81
Ryan, F., Byrne, S., & O’SHEA, S. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03497.x · Cited by 80
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy
Regier, D. A. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051104 · Cited by 78
Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic
Young, S. W., Bishop, L. D., Twells, L., Dillon, C. M., Hawboldt, J., & O'Shea, P. G. (2011) · BMC Family Practice · doi:10.1186/1471-2296-12-88 · Cited by 77
Treatment of venous thromboembolism with rivaroxaban in relation to body weight
Vedovati, M. C., Riera‐Mestre, A., Prins, M. H., Mueller, K., Cohen, A. T., Wells, P. S., Beyer‐Westendorf, J., Prandoni, P., Bounameaux, H., Kubitza, D., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-02-0087 · Cited by 77
Granger, C. B., Lópes, R. D., Hanna, M., Ansell, J., Hylek, E. M., Alexander, J. H., Thomas, L. E., Wang, J., Bahit, M. C., Verheugt, F. W. A., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.09.006 · Cited by 70
Self-citationLalonde, L., Martineau, J., Blais, N., Montigny, M., Ginsberg, J., Fournier, M., Berbiche, D., Vanier, M., Blais, L., Perreault, S., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.009 · Cited by 67
Harrison, J., Shaw, J., & Harrison, J. (2014) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12148 · Cited by 65
Quenet, S., Buchmüller-Cordier, A., Reynaud, J., Tardy-Poncet, B., Thirion, C., Decousus, H., Mismetti, P., & Laporte, S. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613374 · Cited by 61
Wallvik, J., Själander, A., Johansson, L., Bjuhr, Ö., & Jansson, J. (2007) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430601183108 · Cited by 59
Nichol, M. B., Knight, T. K., Dow, T., Wygant, G. D., Borok, G. M., Hauch, O., & O’Connor, R. D. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k157 · Cited by 59
A Visual Medication Schedule to Improve Anticoagulation Control: A Randomized, Controlled Trial
Machtinger, E. L., Wang, F. M., Chen, L.-L., Rodriguez, M., Wu, S., & Schillinger, D. (2007) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(07)33072-9 · Cited by 58
The impact of pharmacist-managed oral anticoagulation therapy in older veterans
Poon, I. O., Lal, L. S., Brown, E. N., & Braun, U. K. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00792.x · Cited by 57
Sharma, P., Scotland, G., Cruickshank, M., Tassie, E., Fraser, C. M., Burton, C. D., Croal, B. L., Ramsay, C. R., & Brazzelli, M. G. (2015) · Health Technology Assessment · doi:10.3310/hta19480 · Cited by 57
Leizorovicz, A., Siguret, V., & Mottier, D. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.03.002 · Cited by 55
Zhou, S., Sheng, X., Xiang, Q., Wang, Z. N., Zhou, Y., & Cui, Y. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12438 · Cited by 53
Patient self‐management of anticoagulation therapy: a trial‐based cost‐effectiveness analysis
Jowett, S. M., Bryan, S., Murray, E. T., McCahon, D., Raftery, J. P., Hobbs, R. F., & Fitzmaurice, D. A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06243.x · Cited by 52
Neiman, A. B., Ruppar, T. M., Ho, P. M., Garber, L., Weidle, P. J., Hong, Y., George, M. G., & Thorpe, P. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14649 · Cited by 52
Godiér, A., Martin, A., Leblanc, I., Mazoyer, E., Horellou, M., Ibrahim, F., Flaujac, C., Golmard, J., Rosencher, N., & Gouin‐Thibault, I. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.08.006 · Cited by 51
Locke, C., Ravnan, S. L., Patel, R. A., & Uchizono, J. A. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.5.685.63582 · Cited by 51
Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists
Eerenberg, E. S., Middeldorp, S., Levi, M. M., Lensing, A. W. A., & Buller, H. R. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13051 · Cited by 50
Low Dose Oral Vitamin K to Reverse Acenocoumarol-induced Coagulopathy: A Randomized Controlled Trial
Crowther, M. A., Steidl, L., Ultori, C., Mera, V., Dentali, F., Squizzato, A., Marchesi, C., Venco, A., & Ageno, W. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613152 · Cited by 49
Self-citationTransition of Patients From Blinded Study Drug to Open-Label Anticoagulation
Ruff, C. T., Giugliano, R. P., Braunwald, E., Mercuri, M. F., Curt, V., Betcher, J., Grip, L. T., Cange, A. L., Crompton, A. E., Murphy, S. A., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.028 · Cited by 48
Wong, P. Y., Schulman, S., Woodworth, S., & Holbrook, A. M. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12107 · Cited by 48
Self-citationSelf-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study)
V�ller, H., Glatz, J., Taborski, U., Bernardo, A., Dovifat, C., & Heidinger, K. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0199-0 · Cited by 46
Hernandez, I., Zhang, Y., Brooks, M. M., Chin, P. K. L., & Saba, S. (2016) · Stroke · doi:10.1161/strokeaha.116.015150 · Cited by 45
Self-citationAgeno, W., Garcia, D. A., Silingardi, M., Galli, M., & Crowther, M. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.022 · Cited by 44
Self-citationChristensen, H., Lauterlein, J.-J., Sørensen, P. D., Petersen, E. R. B., Madsen, J. S., & Brandslund, I. (2011) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2010.0128 · Cited by 44
Koertke, H., Zittermann, A., Wagner, O., et al. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.06.069 · Cited by 44
Washam, J. B., Hellkamp, A. S., Lokhnygina, Y. V., Piccini, J. P., Berkowitz, S. D., Nessel, C. C., Becker, R. C., BREITHARDT, G. E., Fox, K. A. A., Halperin, J. L., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.026 · Cited by 44
Prompt Repeat Testing After Out-of-Range INR Values: A Quality Indicator for Anticoagulation Care
Rose, A. J., Hylek, E. M., Berlowitz, D. R., Ash, A. S., Reisman, J. I., & Ozonoff, A. (2011) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.960096 · Cited by 44
Training for patients in a randomised controlled trial of self management of warfarin treatment
Murray, E. T., Fitzmaurice, D. A., McCahon, D., Fuller, C., & Sandhur, H. (2004) · BMJ · doi:10.1136/bmj.328.7437.437 · Cited by 43
Marini, B. L., Funk, K. A., Kraft, M. D., Fong, J. M., Naanos, R., Stout, S. M., & WAGNER, D. S. (2014) · Patient Education and Counseling · doi:10.1016/j.pec.2014.05.008 · Cited by 43
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding
Wallvik, N., Eriksson, J., Höijer, J., Bottai, M., Holmström, M., Schulman, S., & Majeed, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-07-0498 · Cited by 43
Does self-management of oral anticoagulation therapy improve quality of life and anxiety?
McCahon, D., Murray, E. T., Murray, K. B., Holder, R. L., & Fitzmaurice, D. A. (2010) · Family Practice · doi:10.1093/fampra/cmq089 · Cited by 39
Fondevila, C. G., Grosso, S., Santarelli, M. T., & Pinto, M. D. T. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200101000-00002 · Cited by 35
Witt, D. M., & Humphries, T. L. (2003) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000003325.62542.43 · Cited by 34
Self-citationJones, G. M., Erdman, M. J., Smetana, K. S., Mohrien, K. M., Vandigo, J. E., & Elijovich, L. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1330-3 · Cited by 34
Shalev, V., Rogowski, O., Shimron, O., Sheinberg, B., Shapira, I., Seligsohn, U., Berliner, S. A., & Misgav, M. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.001 · Cited by 33
Ivo Rakovac, A., Kleespies, C., Piso, B., Didjurgeit, U., & Siebenhofer, A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0482 · Cited by 32
Christensen, T. D., Maegaard, M., Sørensen, H. T., Hjortdal, V. E., & Hasenkam, J. M. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.11.021 · Cited by 32
Kimmel, S. E., Troxel, A. B., French, B. C., Loewenstein, G. F., Doshi, J. A., Hecht, T. E. H., Laskin, M. S., Brensinger, C. M., Meussner, C., & Volpp, K. G. M. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4094 · Cited by 28
Thompson, J. L., Burkhart, H. M., Daly, R. C., Dearani, J. A., Joyce, L. D., Suri, R. M., & Schaff, H. V. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.03.088 · Cited by 26
Aziz, F., Corder, M., Wolffe, J., & Comerota, A. J. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.05.021 · Cited by 24
At-Home Versus In-Clinic INR Monitoring: A Cost–Utility Analysis from The Home INR Study (THINRS)
Phibbs, C. S., Love, S. R., Jacobson, A. K., Edson, R., Su, P., Uyeda, L., & Matchar, D. B. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3700-8 · Cited by 24
Matchar, D. B., Love, S. R., Jacobson, A. K., Edson, R., Uyeda, L., Phibbs, C. S., & Dolor, R. J. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-014-1128-8 · Cited by 22
Kumar, R., Smith, R. E., & Henry, B. L. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614527417 · Cited by 19
Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran
Held, V., Eisele, P., Eschenfelder, C. C., & Szabo, K. (2016) · Case Reports in Neurology · doi:10.1159/000452096 · Cited by 19
Chang, J.-Y. A., Wang, C., Kang, H.-C., Shen, L., & Huang, C. (2017) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzx109 · Cited by 19
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
McCahon, D., Fitzmaurice, D. A., Murray, E. T., Fuller, C. J., Hobbs, R. F., Allan, T. F., & Raftery, J. P. (2003) · BMC Family Practice · doi:10.1186/1471-2296-4-11 · Cited by 18
Schaefer, C., Wuillemin, W. A., Kessels, A. G. H., Jacobson, A. K., & Nagler, M. (2016) · British Journal of Haematology · doi:10.1111/bjh.14273 · Cited by 18
Senger, S., Keiner, D., Hendrix, P., & Oertel, J. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.11.086 · Cited by 17
The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban
Pahs, L., Beavers, C. J., & Schuler, P. A. (2015) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000042 · Cited by 15
Effects of computer-assisted oral anticoagulant therapy
Rasmussen, R. S., Corell, P., Madsen, P. V., et al. (2012) · Thrombosis Journal · doi:10.1186/1477-9560-10-17 · Cited by 14
Yoshimura, S., Sato, S., Todo, K., Okada, Y., Furui, E., Matsuki, T., Yamagami, H., Koga, M., TAKAHASHI, J. C., Nagatsuka, K., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.041 · Cited by 13
Dignan, R. J., KEECH, A. C., Gebski, V., Mann, K., & Hughes, C. F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.054 · Cited by 11
Stevanović, J., Postma, M. J., & Le, H. H. (2016) · Value in Health · doi:10.1016/j.jval.2015.12.017 · Cited by 6
Managing oral anticoagulation therapy by pharmacists in a specialty heart hospital
Patel‐Naik, B., Szeinbach, S. L., Seoane-Vazquez, E. C., Snider, M. J., & Hevezi, M. S. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01110.x · Cited by 5
Cited by
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
Hematological findings and complications of COVID‐19
Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25829 · Cited by 1,673
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
“See the ASH guideline on optimal anticoagulant therapy for additional details.(117)”
MethodSelf-citationAntithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Metadata
- Authors
- Witt, D. M., Nieuwlaat, R., Clark, N. P., Ansell, J., Holbrook, A., Skov, J., Shehab, N., Mock, J., Myers, T., Dentali, F., Crowther, M. A., Agarwal, A., Bhatt, M., Khatib, R., Riva, J. J., Zhang, Y., & Guyatt, G.
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2018-11-27
- Volume
- 2
- Issue
- 22
- Pages
- 3257-3291
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- OpenAlex
- W2902233584
- Cited by
- 511
- References
- 152
- FWCI
- 49.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.